Cochrane Database of Systematic Reviews 2016, Issue 12. Art. No.: CD008966. DOI: 10.1002/14651858.CD008966.pub2. 220. Mejhert M, Kahan T, Persson H, Edner M. Limited long term effects of a management programme for heart failure. Heart. 2004; 90(9):1010-5 221. Merit-HF Study Group. Effect of metoprolol CR/XL in chronic heart failure: Metoprolol CR/XL Randomised Intervention Trial in Congestive Heart Failure (MERIT-HF). Lancet. 1999; 222. Moertl D, Berger R, Struck J, Gleiss A, Hammer A, Morgenthaler NG et al. Comparison of midregional pro-atrial and B-type natriuretic peptides in chronic heart failure: influencing factors, detection of left ventricular systolic dysfunction, and prediction of death. Journal of the American College of Cardiology. 2009; 53(19):1783-90 223. Moertl D, Steiner S, Coyle D, Berger R. Cost-utility analysis of NT-proBNP-guided multidisciplinary care in chronic heart failure. International Journal of Technology Assessment in Health Care. 2013; 29(1):3-11 224. Mohiuddin S, Reeves B, Pufulete M, Maishman R, Dayer M, Macleod J et al. Model-based cost-effectiveness analysis of B-type natriuretic peptide-guided care in patients with heart failure. BMJ Open. 2016; 6(12):e014010 225. Molloy GJ, Johnston DW, Witham MD. Family caregiving and congestive heart failure. Review and analysis. European Journal of Heart Failure. 2005; 7(4):592-603 226. Monahan M, Barton P, Taylor CJ, Roalfe A, Hobbs R. MICE or NICE? An Economic Evaluation of clinical decision rules in the diagnosis of Heart Failure in Primary Care. International Journal of Cardiology. 2017; 241:255-261 227. Morrison LJ, Calvin AO, Nora H, Porter Storey C. Managing cardiac devices near the end of life: A survey of hospice and palliative care providers. American Journal of Hospice & 228. Mortara A, Pinna GD, Johnson P, Maestri R, Capomolla S, La Rovere MT et al. Home telemonitoring in heart failure patients: the HHH study (Home or Hospital in Heart Failure). European Journal of Heart Failure. 2009; 11(3):312-8 229. 